Research Suggests Proton Pump Inhibitors May Help Limit Fibrosis in Eosinophilic Esophagitis - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Research Suggests Proton Pump Inhibitors May Help Limit Fibrosis in Eosinophilic Esophagitis

  • By

  • November 11, 2026

  • 6 min

Share

  • 1

    Research led by Colby S. Sharlin, MD, found that proton pump inhibitors may have anti-fibrotic effects in eosinophilic esophagitis (EoE), in clinical cohorts and basic science experiments.

  • 2

    Fibrosis is the main driver of EoE complications and may progress to esophageal strictures, which can impair quality of life and require dilation.

  • 3

    Choking and food impaction may signal fibrosis, while endoscopy can show narrowing, strictures, or rings and biopsy can detect microscopic scarring.

  • 4

    PPI treatment decisions at Phoenix Children’s involve shared decision-making and consideration of each child’s medical history, nutritional status, and ability to take medication orally.

  • 5

    Follow-up evaluation, typically with sedated upper endoscopy, is needed to assess treatment response; sedation-free monitoring options include transnasal endoscopy and the esophageal string test.

Original Source(s)

Related Content